HROWM News and Press, Harrow Inc. 11.875% Senior Notes due 2027 From 05/10/25

2025-05-10 18:17:15 ET Harrow, Inc. (HROW) Q1 2025 Results Conference Call May 9, 2025 8:00 AM ET Company Participants Jamie Webb - Director, Communications & IR Mark Baum - CEO Andrew Boll - CFO Conference Call Participants Thomas Flaten - Lake S...

2025-04-29 07:35:00 ET Summary Life is inherently unpredictable. But you can minimize its effects on your financial well-being. Dividends offer peace of mind and consistent income, making your retirement less vulnerable to market volatility. We discuss our top picks offering d...

2025-03-29 16:30:00 ET Summary Harrow's stock is down 17% since my last analysis and "Sell" recommendation. Harrow's Q4 and FY24 results show significant revenue growth and improved net income, but the company faces complex reimbursement challenges and tough competition. Valua...

2025-03-28 14:00:40 ET Harrow, Inc. (HROW) Q4 2024 - Earnings Conference Call March, 28, 2025, 8:00 AM ET Company Participants Jamie Webb - Director, Communications & IR Mark Baum - CEO Andrew Boll - CFO Conference Call Participants ...

2025-03-28 13:39:25 ET Summary Harrow, Inc. is a speculative buy, with potential trading gains from the $20s to the $30s, and long-term growth prospects. The company reported strong Q4 growth, with an 84% revenue increase and improved gross profit margins, driven by key products I...

2025-03-01 08:50:08 ET Summary Harrow Health's robust distribution platform and patented eye care products create a strong moat, offering an attractive entry point after the recent stock price correction. Catalysts in 2025 could come from a successful Triesence launch and potentia...

2025-02-28 00:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-02-17 09:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-02-17 07:35:00 ET Summary Innovation, demand, and shortage of providers have kept healthcare inflation significantly higher than the CPI. Regardless of the political scene, the aging U.S. population and rising chronic illnesses are undeniable truths to face. Income invest...

2025-02-17 03:35:00 ET Summary Elevated market expectations and speculative trading, reminiscent of past bubbles, suggest potential overvaluation and a high risk of disappointing returns. U.S. tech stocks and S&P 500 are trading at historically high multiples, with earnings gr...